PMID- 30115944 OWN - NLM STAT- MEDLINE DCOM- 20191030 LR - 20191030 IS - 2045-2322 (Electronic) IS - 2045-2322 (Linking) VI - 8 IP - 1 DP - 2018 Aug 16 TI - The polymorphism rs35767 at IGF1 locus is associated with serum urate levels. PG - 12255 LID - 10.1038/s41598-018-29665-3 [doi] LID - 12255 AB - Previous studies suggested that the IGF-1/IGF-1 receptor signaling pathway may contribute to regulate uric acid levels. To confirm this hypothesis, we assessed the effects of the IGF-1-raising genetic variant rs35767 on urate levels in serum and urine, and we investigated IGF-1 ability to modulate the expression of transporters involved in reabsorption and secretion of uric acid in the kidney. The study population included 2794 adult Whites. 24-hour urinary uric acid concentration was available for 229 subjects. rs35767 polymorphism was screened using TaqMan genotyping assays. HEK293 (human embryonic kidney-293) cell line was treated with IGF-1 (1, 5, 10, 50 nM) for 24-hours, and differences in the expression of urate transporters were evaluated via Western Blot and real time rtPCR. Individuals carrying the IGF-1-raising allele (rs35767 T) exhibited significantly lower levels of serum urate according to both additive and recessive models, after correction for gender, age, BMI, glucose tolerance, glomerular filtration rate, and anti-hypertensive treatment. TT genotype carriers displayed higher uricosuria than C allele carriers did, after adjusting for confounders. Exposure of HEK293 cells to IGF-1 resulted in a dose-dependent increase of uric acid transporters deputed to uric acid excretion (MRP4, NPT1 and BCRP), and reduction of GLUT9 expression, the major mediator of uric acid reabsorption, both at mRNA and protein level. We observed a significant association between the functional polymorphism rs35767 near IGF1 with serum urate concentrations and we provide a mechanistic explanation supporting a causal role for IGF-1 in the regulation of uric acid homeostasis. FAU - Mannino, Gaia C AU - Mannino GC AUID- ORCID: 0000-0002-6341-4572 AD - Department of Medical and Surgical Sciences, University "Magna Graecia" of Catanzaro, Catanzaro, Italy. FAU - Fuoco, Anastasia AU - Fuoco A AD - Department of Medical and Surgical Sciences, University "Magna Graecia" of Catanzaro, Catanzaro, Italy. FAU - Marini, Maria A AU - Marini MA AD - Department of Systems Medicine, University of Rome-Tor Vergata, Rome, Italy. FAU - Spiga, Rosangela AU - Spiga R AD - Department of Medical and Surgical Sciences, University "Magna Graecia" of Catanzaro, Catanzaro, Italy. FAU - Di Fatta, Concetta AU - Di Fatta C AD - Department of Medical and Surgical Sciences, University "Magna Graecia" of Catanzaro, Catanzaro, Italy. FAU - Mancuso, Elettra AU - Mancuso E AD - Department of Medical and Surgical Sciences, University "Magna Graecia" of Catanzaro, Catanzaro, Italy. FAU - Perticone, Francesco AU - Perticone F AD - Department of Medical and Surgical Sciences, University "Magna Graecia" of Catanzaro, Catanzaro, Italy. FAU - Andreozzi, Francesco AU - Andreozzi F AUID- ORCID: 0000-0001-9375-1513 AD - Department of Medical and Surgical Sciences, University "Magna Graecia" of Catanzaro, Catanzaro, Italy. andreozzif@unicz.it. FAU - Sesti, Giorgio AU - Sesti G AD - Department of Medical and Surgical Sciences, University "Magna Graecia" of Catanzaro, Catanzaro, Italy. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20180816 PL - England TA - Sci Rep JT - Scientific reports JID - 101563288 RN - 0 (IGF1 protein, human) RN - 0 (Organic Anion Transporters) RN - 0 (RNA, Messenger) RN - 0 (urate transporter) RN - 268B43MJ25 (Uric Acid) RN - 67763-96-6 (Insulin-Like Growth Factor I) SB - IM MH - Female MH - Gene Expression Regulation/genetics MH - Genetic Loci/*genetics MH - HEK293 Cells MH - Humans MH - Insulin-Like Growth Factor I/*genetics MH - Male MH - Middle Aged MH - Organic Anion Transporters/genetics MH - *Polymorphism, Single Nucleotide MH - RNA, Messenger/genetics/metabolism MH - Uric Acid/*blood PMC - PMC6095867 COIS- The authors declare no competing interests. EDAT- 2018/08/18 06:00 MHDA- 2019/10/31 06:00 PMCR- 2018/08/16 CRDT- 2018/08/18 06:00 PHST- 2018/03/19 00:00 [received] PHST- 2018/07/12 00:00 [accepted] PHST- 2018/08/18 06:00 [entrez] PHST- 2018/08/18 06:00 [pubmed] PHST- 2019/10/31 06:00 [medline] PHST- 2018/08/16 00:00 [pmc-release] AID - 10.1038/s41598-018-29665-3 [pii] AID - 29665 [pii] AID - 10.1038/s41598-018-29665-3 [doi] PST - epublish SO - Sci Rep. 2018 Aug 16;8(1):12255. doi: 10.1038/s41598-018-29665-3.